Published in J Gastrointest Surg on May 29, 2009
Diagnostic accuracy of C-reactive protein and white blood cell counts in the early detection of inflammatory complications after open resection of colorectal cancer: a retrospective study of 1,187 patients. Int J Colorectal Dis (2011) 1.91
Diagnostic value of C-reactive protein to rule out infectious complications after major abdominal surgery: a systematic review and meta-analysis. Int J Colorectal Dis (2015) 1.41
C-reactive protein is an early predictor of septic complications after elective colorectal surgery. World J Surg (2010) 1.24
Inflammatory markers as predictors of surgical site infection after elective colorectal cancer surgery. Langenbecks Arch Surg (2014) 1.06
Comparison of C-reactive protein and procalcitonin as predictors of postoperative infectious complications after elective colorectal surgery. Croat Med J (2012) 1.01
Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications. World J Surg (2011) 0.99
C-reactive protein as an early predictor for anastomotic leakage in elective abdominal surgery. Tech Coloproctol (2013) 0.93
Diagnostic accuracy of C-reactive protein and procalcitonin in the early detection of infection after elective colorectal surgery - a pilot study. BMC Infect Dis (2014) 0.86
C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection. Gastric Cancer (2015) 0.84
Impact of day 2 C-reactive protein on day 3 and 4 thresholds associated with infective complications following curative surgery for colorectal cancer. World J Surg (2013) 0.84
The role of C-reactive protein and the SOFA score as parameter for clinical decision making in surgical patients during the intensive care unit course. PLoS One (2013) 0.79
C-reactive protein is a predictor of complications after elective laparoscopic colorectal surgery: five-year experience. Wideochir Inne Tech Maloinwazyjne (2015) 0.78
Diagnostic markers of postoperative morbidity after laparoscopic Roux-en-Y gastric bypass for obesity. Langenbecks Arch Surg (2014) 0.78
Compression anastomotic ring-locking procedure (CARP) is a safe and effective method for intestinal anastomoses following left-sided colonic resection. Int J Colorectal Dis (2015) 0.77
Searching for predictors of surgical complications in critically ill surgery patients in the intensive care unit: a review. Surg Today (2015) 0.77
Predictive Value of C-Reactive Protein for Major Complications after Major Abdominal Surgery: A Systematic Review and Pooled-Analysis. PLoS One (2015) 0.75
Predictive value of C-reactive protein in critically ill patients after abdominal surgery. Clinics (Sao Paulo) (2017) 0.75
Ability of Serum C-Reactive Protein Concentrations to Predict Complications After Laparoscopy-Assisted Gastrectomy: A Prospective Cohort Study. Medicine (Baltimore) (2016) 0.75
Diagnostic accuracy of the postoperative ratio of C-reactive protein to albumin for complications after colorectal surgery. World J Surg Oncol (2017) 0.75
Inflammatory markers as predictors of surgical site infection after elective colorectal surgery: authors' reply. Langenbecks Arch Surg (2014) 0.75
Value of procalcitonin as a biomarker for postoperative hospital-acquired pneumonia after abdominal surgery. Korean J Anesthesiol (2017) 0.75
Factors affecting serum albumin in the perioperative period of colorectal surgery: a retrospective study. BMC Res Notes (2015) 0.75
Clinical evaluation of C-reactive protein and procalcitonin for the early detection of postoperative complications after laparoscopic sleeve gastrectomy. Wideochir Inne Tech Maloinwazyjne (2017) 0.75
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem (2008) 2.44
High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis (2010) 1.87
Lymph node harvest in colon cancer: influence of microsatellite instability and proximal tumor location. World J Surg (2009) 1.73
Trauma systems and early management of severe injuries in Scandinavia: review of the current state. Injury (2009) 1.43
Will surgeons' continuity of care strikeout or hit a home run? Am J Surg (2009) 1.40
Tidsskr Nor Laegeforen (2017) 1.39
Acute scrotum and Henoch-Schönlein purpura. Acta Paediatr (2007) 1.39
[Colorectal cancer--a disease one doesn't talk about]. Tidsskr Nor Laegeforen (2007) 1.39
[Surgical treatment of pilonidal disease]. Tidsskr Nor Laegeforen (2010) 1.37
Banking of biological fluids for studies of disease-associated protein biomarkers. Mol Cell Proteomics (2008) 1.27
Trends in diagnosis and surgical management of patients with perforated peptic ulcer. J Gastrointest Surg (2011) 1.24
Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. Clin Cancer Res (2002) 1.23
Epidemiology of perforated peptic ulcer: age- and gender-adjusted analysis of incidence and mortality. World J Gastroenterol (2013) 1.19
"Getting your message through": an editorial guide for meeting publication standards. Scand J Trauma Resusc Emerg Med (2009) 1.19
High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer (2002) 1.18
Diagnostic accuracy and receiver-operating characteristics curve analysis in surgical research and decision making. Ann Surg (2011) 1.14
VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol Neurotol (2005) 1.07
Routine whole-body computed tomography in major trauma resuscitation: From "donut of death" to "do not without"? J Trauma Acute Care Surg (2015) 1.06
Circulating VEGF as a biological marker in patients with rheumatoid arthritis? Preanalytical and biological variability in healthy persons and in patients. Dis Markers (2008) 1.04
Incidence of traumatic long-bone fractures requiring in-hospital management: a prospective age- and gender-specific analysis of 4890 fractures. Injury (2009) 1.04
Risk of anastomotic leakage with use of NSAIDs after gastrointestinal surgery. Int J Colorectal Dis (2011) 1.04
Benign peritoneal cystic mesothelioma. World J Surg (2006) 1.03
Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects. Cancer Epidemiol Biomarkers Prev (2008) 1.01
Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment. Scand J Gastroenterol (2008) 1.01
TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid. Clin Cancer Res (2007) 1.00
Submission policy, peer-review and editorial board members: interesting conflicts and conflicts of interest. Scand J Trauma Resusc Emerg Med (2010) 1.00
Epidemiology of gastrointestinal stromal tumours: single-institution experience and clinical presentation over three decades. Cancer Epidemiol (2011) 0.99
Outcome of patients with esophageal perforations: a multicenter study. World J Surg (2014) 0.96
Data fusion in metabolomic cancer diagnostics. Metabolomics (2012) 0.95
Scoring systems for outcome prediction in patients with perforated peptic ulcer. Scand J Trauma Resusc Emerg Med (2013) 0.94
Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals. J Transl Med (2013) 0.94
Qualitative and quantitative issues of lymph nodes as prognostic factor in colon cancer. Dig Surg (2013) 0.94
Syncytin immunoreactivity in colorectal cancer: potential prognostic impact. Cancer Lett (2009) 0.93
Molecular pathways and cellular metabolism in colorectal cancer. Dig Surg (2013) 0.92
Rapid and individual-specific glycoprofiling of the low abundance N-glycosylated protein tissue inhibitor of metalloproteinases-1. Mol Cell Proteomics (2007) 0.92
Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer. Cancer Immunol Immunother (2004) 0.92
Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort. PLoS One (2013) 0.92
Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors. Clin Rheumatol (2010) 0.92
Surgery in Norway: beyond the scalpel in the 21st century. Arch Surg (2008) 0.92
Bile duct cyst as precursor to biliary tract cancer. Ann Surg Oncol (2006) 0.91
Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: relation to recurrence and mortality. Clin Cancer Res (2005) 0.91
Long-term stability and circadian variation in circulating levels of surfactant protein D. Immunobiology (2009) 0.91
Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue. Anticancer Res (2007) 0.91
Leading-edge myofibroblasts in human colon cancer express plasminogen activator inhibitor-1. Am J Clin Pathol (2004) 0.90
TOP1 gene copy numbers in colorectal cancer samples and cell lines and their association to in vitro drug sensitivity. Scand J Gastroenterol (2012) 0.90
Patients Referred to a Norwegian Trauma Centre: effect of transfer distance on injury patterns, use of resources and outcomes. J Trauma Manag Outcomes (2011) 0.90
Epidemiology of trauma: a population-based study of geographical risk factors for injury deaths in the working-age population of Norway. Injury (2013) 0.90
Genetic and epigenetic traits as biomarkers in colorectal cancer. Int J Mol Sci (2011) 0.90
Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer. Cancer Med (2014) 0.89
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay. Clin Chem (2002) 0.89
Localization of tissue inhibitor of metalloproteinases 1 (TIMP-1) in human colorectal adenoma and adenocarcinoma. Int J Cancer (2005) 0.89
Topoisomerase 1(TOP1) gene copy number in stage III colorectal cancer patients and its relation to prognosis. Mol Oncol (2012) 0.88
Qualities of sessile serrated adenoma/polyp/lesion and its borderline variant in the context of synchronous colorectal carcinoma. J Clin Pathol (2012) 0.87
Steppingstones to the implementation of an inhospital fracture and dislocation registry using the AO/OTA classification: compliance, completeness and commitment. Scand J Trauma Resusc Emerg Med (2010) 0.87
Prognostic relevance of androgen receptor detection in operable breast cancer. J Surg Oncol (2008) 0.87
Plasma TIMP-1 in patients with colorectal adenomas: a prospective study. Eur J Cancer (2004) 0.87
Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist. Surg Oncol (2008) 0.87
What is the best predictor of mortality in perforated peptic ulcer disease? A population-based, multivariable regression analysis including three clinical scoring systems. J Gastrointest Surg (2014) 0.87
Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome. Clin Transl Oncol (2012) 0.86
Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection. Cancer (2009) 0.86
Collecting core data in severely injured patients using a consensus trauma template: an international multicentre study. Crit Care (2011) 0.86
Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era. Scand J Gastroenterol (2014) 0.86
How reliable and accurate is the AO/OTA comprehensive classification for adult long-bone fractures? J Trauma Acute Care Surg (2012) 0.86
Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer. Eur J Cancer (2006) 0.85
Emerging concepts of apolipoprotein D with possible implications for breast cancer. Cell Oncol (2007) 0.85
Excess mortality after curative surgery for colorectal cancer changes over time and differs for patients with colon versus rectal cancer. Acta Oncol (2012) 0.85
Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer. Scand J Gastroenterol (2008) 0.85
Establishment and characterization of 7 new monoclonal antibodies to tissue inhibitor of metalloproteinases-1. Tumour Biol (2005) 0.85
Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients. Ann Surg Oncol (2012) 0.84
Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 -a prognostic marker in colorectal cancer. Hum Immunol (2008) 0.84
Reliable classification of children's fractures according to the comprehensive classification of long bone fractures by Müller. Acta Orthop (2012) 0.84
Prognostic role of carcinoembryonic antigen is influenced by microsatellite instability genotype and stage in locally advanced colorectal cancers. World J Surg (2011) 0.83
Contemporary use of endoscopic retrograde cholangiopancreatography (ERCP): a Norwegian prospective, multicenter study. Scand J Gastroenterol (2011) 0.82
Cathepsin X in serum from patients with colorectal cancer: relation to prognosis. Radiol Oncol (2012) 0.82
Investigating the biomarker potential of glycoproteins using comparative glycoprofiling - application to tissue inhibitor of metalloproteinases-1. Biochim Biophys Acta (2007) 0.82
Assessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer. Scand J Gastroenterol (2013) 0.82
Haemostatic alterations in colorectal cancer: perspectives for future treatment. J Surg Oncol (2004) 0.82
Non-synonymous polymorphisms in the FCN1 gene determine ligand-binding ability and serum levels of M-ficolin. PLoS One (2012) 0.81
Angiogenesis in vestibular schwannomas: expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1. Laryngoscope (2010) 0.81
VEGF and tumour angiogenesis. Impact of surgery, wound healing, inflammation and blood transfusion. Scand J Gastroenterol (2002) 0.80
Type II error in a randomized controlled trial of appendectomy vs. antibiotic treatment of acute appendicitis. World J Surg (2007) 0.80
VEGF concentrations in tumour arteries and veins from patients with rectal cancer. APMIS (2002) 0.80
Trimodal temporal distribution of fatal trauma--fact or fiction? Injury (2008) 0.80
Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Acta Oncol (2009) 0.79
Endoscopy, morphology, morphometry and molecular markers: predicting cancer risk in colorectal adenoma. Expert Rev Mol Diagn (2009) 0.79